As discussed above, in the HBV-encoded X protein (HBx)-induced mouse HCC model, the thyroid hormone was reported to decrease HCC incidence through activating the PINK1/Parkin pathway to induce mitophagy in hepatocytes, consequently reducing the ROS inflicted DNA damage [181]. This evidence concerns the gene PRKN and hepatocellular carcinoma.